Covid-19 has thrown telehealth into the spotlight as it reduces the chance of cross-infection at hospitals and supports millions of recovered patients’ rehabilitation. Considering at-home bio-imaging technology to be the backbone of telemedicine, HKTDC Research sat down with Justin Chan, the CEO of Gense Technologies to learn how the award-winning start-up has been working in the field and enabling the early, preclinical screening of body parts, including the lungs, the tendons and the liver. More